Virtual reality may ease Pre-Surgery anxiety in breast cancer patients
NCT ID NCT07785245
First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time
Summary
This pilot trial tests whether a brief virtual reality (VR) experience can help breast cancer patients feel calmer in the waiting period just before surgery. Sixty women scheduled for breast cancer surgery will be randomly assigned to either an 8-minute guided mindfulness meditation in a virtual beach setting, an 8-minute immersive nature scene without guidance, or standard care. The study focuses on whether the VR approach is feasible and acceptable, and also measures changes in anxiety levels before and after the intervention.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Immersive virtual reality mindfulness meditation or immersive nature virtual reality
- What this could lead to
- If effective, this could offer a drug-free way to calm breast cancer patients' anxiety in the moments before surgery, improving their experience without medication.
- What could go wrong
- This is a small pilot study focused on feasibility and tolerability, not proof of effectiveness. Some people may feel cybersickness or dizziness from the VR headset, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Female patients aged 18 years or older Capable of providing written informed consent Scheduled for elective breast cancer surgery requiring general anaesthesia Possessing sufficient vision and hearing to engage with the VR experience Exclusion Criteria: Severe visual or auditory impairments Cognitive deficits that would preclude engagement with the VR hardware A history of motion sickness or known contraindications to VR exposure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Champalimaud Foundation - Breast Unit
Lisbon, Lisbon District, 1400-038, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Retrospective analysis of pyrotinib in the treatment of HER2-Positive advanced breast cancer previously treated with trastuzumab and pertuzumab
- Mind and body: does resilience leave a molecular mark in breast cancer?
- Which pain block works better for breast surgery?
- Can a Triple-Drug combo erase HER2-Positive breast tumors before surgery?
- Bacteria inside tumors may hold the key to breast cancer treatment
- Can a newer drug ease the bone pain of chemotherapy support?